Can baseline quality of life scores predict for morbidity and survival after CRS and HIPEC: a prospective study of 151 patients

Abstract

Various studies have shown that good quality of life (QoL) can be achieved after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). There is prognostic value of baseline QoL in post-operative outcome in Western setting. Our prospective study aims to validate these observations and elucidate clinical factors that predict poorer QoL in Asian peritoneal carcinomatosis patients.

Keywords

• baseline qol
• cytoreductive surgery (crs)
• hyperthermic intraperitoneal chemotherapy (hipec)
• peritoneal carcinomatosis